ID
45764
Beskrivning
Principal Investigator: Chanock SJ, MD, National Cancer Institute, Bethesda, MD, USA MeSH: Thyroid Cancer, Papillary,Chernobyl Nuclear Accident,Neoplasms, Radiation-Induced,Iodine Radioisotopes https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001134 The April 26, 1986 accident at the Chernobyl nuclear power plant in northern Ukraine resulted in the release of radioactive contaminants, which were deposited in the surrounding areas in Ukraine, Belarus, and Russia. The main radiation-related health effect resulting from these exposures is the increased occurrence of thyroid cancer among individuals who were children at the time of the accident or born shortly thereafter. The purpose of this study was to conduct a comprehensive genomic landscape analysis of papillary thyroid tumors arising in individuals who were exposed as children to radioactive iodine (I-131) from the Chernobyl nuclear power plant accident.
Länk
Nyckelord
Versioner (1)
- 2023-06-16 2023-06-16 - Chiara Middel
Rättsinnehavare
Chanock SJ, MD, National Cancer Institute, Bethesda, MD, USA
Uppladdad den
16 juni 2023
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
dbGaP phs001134 Radiation-related Genomic Profile of Papillary Thyroid Cancer after the Chernobyl Accident
Subject ID, family ID, father, mother, monozygous twins, and sex of participants with papillary thyroid cancer and involved in the "Radiation-related Genomic Profile of Papillary Thyroid Cancer after the Chernobyl Accident" project.
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID and sample ID of participants with papillary thyroid cancer and involved in the "Radiation-related Genomic Profile of Papillary Thyroid Cancer after the Chernobyl Accident" project.
- Subject ID, family ID, father, mother, monozygous twins, and sex of participants with papillary thyroid cancer and involved in the "Radiation-related Genomic Profile of Papillary Thyroid Cancer after the Chernobyl Accident" project.
- Sample ID, analyte type, body site where sample was obtained, histological type, and tumor status of sample obtained from participants with papillary thyroid cancer and involved in the "Radiation-related Genomic Profile of Papillary Thyroid Cancer after the Chernobyl Accident" project.
- Subject ID, sex, affection status, age, radiation dose, and diagnosis of participants with papillary thyroid cancer and involved in the "Radiation-related Genomic Profile of Papillary Thyroid Cancer after the Chernobyl Accident" project.
- Subject ID, consent group, and sex of participants with papillary thyroid cancer and involved in the "Radiation-related Genomic Profile of Papillary Thyroid Cancer after the Chernobyl Accident" project.
Similar models
Subject ID, family ID, father, mother, monozygous twins, and sex of participants with papillary thyroid cancer and involved in the "Radiation-related Genomic Profile of Papillary Thyroid Cancer after the Chernobyl Accident" project.
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID and sample ID of participants with papillary thyroid cancer and involved in the "Radiation-related Genomic Profile of Papillary Thyroid Cancer after the Chernobyl Accident" project.
- Subject ID, family ID, father, mother, monozygous twins, and sex of participants with papillary thyroid cancer and involved in the "Radiation-related Genomic Profile of Papillary Thyroid Cancer after the Chernobyl Accident" project.
- Sample ID, analyte type, body site where sample was obtained, histological type, and tumor status of sample obtained from participants with papillary thyroid cancer and involved in the "Radiation-related Genomic Profile of Papillary Thyroid Cancer after the Chernobyl Accident" project.
- Subject ID, sex, affection status, age, radiation dose, and diagnosis of participants with papillary thyroid cancer and involved in the "Radiation-related Genomic Profile of Papillary Thyroid Cancer after the Chernobyl Accident" project.
- Subject ID, consent group, and sex of participants with papillary thyroid cancer and involved in the "Radiation-related Genomic Profile of Papillary Thyroid Cancer after the Chernobyl Accident" project.
C0030761 (UMLS CUI [1,2])
C0030761 (UMLS CUI [1,2])
C2348585 (UMLS CUI [1,2])
C0030761 (UMLS CUI [1,3])